“…This effect, observed with enzyme preparations from heart, kidney, brain and skeletal muscle from normal adult rats, has not been studied for CoA-transferases from tissues of diabetic animals, where such an inhibition could contribute to the apparently impaired tissue utilization of ketone bodies in these animals and to their development of pathological ketosis (Beatty et al, 1960;Balasse & Havel, 1971;Bates, 1972;Bassler et al, 1973;Ruderman & Goodman, 1974). We have focused our studies on skeletal-muscle CoAtransferase in diabetic rats, because skeletal muscle is the major consuming tissue for ketone bodies (Bassler et al, 1973) and because uncertainty exists about the extent of transferase activity in chronically diabetic rat muscle (Bassler et al, 1973;Williamson et al, 1971 The procedures described previously (Fenselau & Wallis, 1974b;Fenselau et al, 1975) were followed in order to obtain a total homogenate of hindquarter skeletal muscle in either 0.02M-potassium phosphate (pH7.0) or a Tris/KCl solution (pH7.4) containing 50mM-Tris/HCI, 0.1 M-KCI, 5mM-MgSO4, 1 mM-ATP and 1 mM-EDTA. The CoA-transferase activity in the phosphate medium, when necessary, could be concentrated by batchwise adsorption of the enzyme on alumina C, gel (Bio-Rad Laboratories, Richmond, CA, U.S.A.), followed by elution with a smaller volume of 0.25M-potassium phosphate (pH8.0).…”